Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?
Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?
7-9
Huneke, Nathan
7e4a84ba-5aed-4966-adf2-58a92a0b4284
September 2022
Huneke, Nathan
7e4a84ba-5aed-4966-adf2-58a92a0b4284
Huneke, Nathan
(2022)
Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?
European Neuropsychopharmacology, 62, .
(doi:10.1016/j.euroneuro.2022.06.003).
Text
Medication_efficacy_measures_V2_noannotations
- Accepted Manuscript
Text
1-s2.0-S0924977X22002176-main
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 9 June 2022
e-pub ahead of print date: 7 July 2022
Published date: September 2022
Additional Information:
Funding Information:
NTMH is a clinical research training fellow supported by the MRC (grant number MR/T000902/1). He has also consulted for Emteq Ltd within the last 3 years.
Identifiers
Local EPrints ID: 468353
URI: http://eprints.soton.ac.uk/id/eprint/468353
ISSN: 0924-977X
PURE UUID: 2938547c-560a-4830-94f5-bf258499e10b
Catalogue record
Date deposited: 11 Aug 2022 16:30
Last modified: 17 Mar 2024 07:25
Export record
Altmetrics
Contributors
Author:
Nathan Huneke
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics